{"filing":{"accession_number":"0001185185-26-002359","cik":"0001864531","ticker":"VSEEW","company_name":"VSEE HEALTH, INC.","form":"8-K","filing_date":"2026-06-05","report_date":null,"primary_document":"vsee8k060526.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1864531/000118518526002359/vsee8k060526.htm"},"events":[{"id":3790,"run_id":3325,"accession_number":"0001185185-26-002359","anchor_item_number":null,"event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.85,"summary":"The filing discloses a material disposition of assets: VSee Health sold all equity securities of its wholly-owned subsidiary VSee Lab to Milton Chen (the co-CEO and Chairman) in exchange for Chen's transfer of 2,870,069 shares of common stock to the Company. This is a significant restructuring involving a change of control of a subsidiary and a material equity transaction, disclosed under Items 1.01 (Entry into Material Definitive Agreement), 2.01 (Completion of Acquisition or Disposition of Assets), and 3.02 (Unregistered Sales of Equity Securities). While an executive departure also occurs (Chen's resignation as co-CEO and Chairman), the central disclosed event is the asset disposition and equity swap transaction.","company_name":"VSEE HEALTH, INC.","ticker":"VSEEW","filing_date":"2026-06-05","items":null}],"classifications":[{"id":4807,"accession_number":"0001185185-26-002359","item_number":null,"item_title":null,"event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.85,"reasoning":"The filing discloses a material disposition of assets: VSee Health sold all equity securities of its wholly-owned subsidiary VSee Lab to Milton Chen (the co-CEO and Chairman) in exchange for Chen's transfer of 2,870,069 shares of common stock to the Company. This is a significant restructuring involving a change of control of a subsidiary and a material equity transaction, disclosed under Items 1.01 (Entry into Material Definitive Agreement), 2.01 (Completion of Acquisition or Disposition of Assets), and 3.02 (Unregistered Sales of Equity Securities). While an executive departure also occurs (Chen's resignation as co-CEO and Chairman), the central disclosed event is the asset disposition and equity swap transaction.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-05T20:18:15.733243+00:00","company_name":"VSEE HEALTH, INC.","ticker":"VSEEW","filing_date":"2026-06-05"}]}